Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

C4 Therapeutics (CCCC) Interest & Investment Income: 2019-2024

Historic Interest & Investment Income for C4 Therapeutics (CCCC) over the last 6 years, with Dec 2024 value amounting to $14.4 million.

  • C4 Therapeutics' Interest & Investment Income fell 37.23% to $2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.8 million, marking a year-over-year decrease of 23.21%. This contributed to the annual value of $14.4 million for FY2024, which is 47.05% up from last year.
  • Latest data reveals that C4 Therapeutics reported Interest & Investment Income of $14.4 million as of FY2024, which was up 47.05% from $9.8 million recorded in FY2023.
  • C4 Therapeutics' Interest & Investment Income's 5-year high stood at $14.4 million during FY2024, with a 5-year trough of $387,000 in FY2021.
  • Moreover, its 3-year median value for Interest & Investment Income was $9.8 million (2023), whereas its average is $9.3 million.
  • In the last 5 years, C4 Therapeutics' Interest & Investment Income slumped by 81.78% in 2020 and then skyrocketed by 823.77% in 2022.
  • Yearly analysis of 5 years shows C4 Therapeutics' Interest & Investment Income stood at $393,000 in 2020, then fell by 1.53% to $387,000 in 2021, then spiked by 823.77% to $3.6 million in 2022, then skyrocketed by 174.46% to $9.8 million in 2023, then surged by 47.05% to $14.4 million in 2024.